IperionX Limited Sponsored ADR (IPX) – What Are Investment Firms Thinking About This Stock?

IperionX Limited Sponsored ADR (NASDAQ:IPX) has received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $42.00.

A number of research analysts recently weighed in on the company. Jefferies Financial Group assumed coverage on IperionX in a report on Wednesday, September 2nd. They issued a “buy” rating and a $26.00 target price on the stock. B. Riley Financial dropped their price target on IperionX from $52.00 to $34.00 and set a “buy” rating for the company in a research note on Wednesday, September 30th. Roth Capital set a $53.00 price objective on IperionX in a report on Wednesday, August 5th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a report on Thursday.

IperionX Stock Performance

Shares of IPX opened at $14.20 on Tuesday. IperionX has a 1-year low of $13.14 and a 1-year high of $61.45. The company has a quick ratio of 2.95, a current ratio of 3.24 and a debt-to-equity ratio of 0.04. The firm’s 50-day moving average price is $19.88 and its 200-day moving average price is $26.99.

IperionX (NASDAQ:IPX) last announced its quarterly earnings data on Thursday, July 30th. The company reported ($0.50) EPS for the quarter. As a group, equities analysts expect that IperionX will post -0.13 earnings per share for the current year.

Institutional Trading of IperionX

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Private Advisor Group LLC increased its position in shares of IperionX by 69.9% during the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock worth $1,643,000 after buying an additional 25,964 shares during the period. Connective Capital Management LLC acquired a new position in IperionX during the second quarter worth $160,000. GAMMA Investing LLC increased its holdings in IperionX by 40.3% during the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock worth $50,000 after purchasing an additional 483 shares in the last quarter. DLD Asset Management LP purchased a new stake in shares of IperionX in the first quarter valued at about $260,000. Finally, Corigliano Investment Advisers LLC bought a new position in shares of IperionX in the fourth quarter valued at approximately $362,000. Institutional investors and hedge funds own 2.76% of the company’s stock.

IperionX Company Profile

IperionX Limited (NASDAQ: IPX) is a materials technology company focused on developing a U.S.-based, lower-carbon titanium supply chain. The company is working to produce titanium metal, powder and other titanium products for aerospace, defense, automotive, medical and other advanced manufacturing applications.

IperionX is developing its Titan Project in Tennessee, which is designed to supply titanium minerals and support domestic production of titanium products. The project is intended to integrate the processing of titanium mineral resources with downstream manufacturing, reducing reliance on overseas sources of titanium.

The company is also advancing proprietary processing technologies, including its Hydrogen Assisted Metallothermic Reduction process, which is designed to produce titanium metal and powder with lower energy requirements than conventional methods.